PillRizatriptan Benzoate
Brands: Maxalt · Rizatriptan Benzoate
14 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it14 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 17 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 10 | SUPPLYING |
| Creekwood Pharmaceuticals LLC | unknown | 8 | SUPPLYING |
| Direct_Rx | unknown | 6 | SUPPLYING |
| Cipla USA Inc. | unknown | 4 | SUPPLYING |
| Unichem Pharmaceuticals (USA), Inc. | unknown | 4 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 4 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 4 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 4 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 4 | SUPPLYING |
| Proficient Rx LP | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 2 | SUPPLYING |
| Organon LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 9, 2025RECALLRecall (Class II): Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd.,…
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit. — Recalling firm: Ascend Laboratories, LLC — US Nationwide.
- Jul 9, 2025RECALLRecall (Class II): Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd.…
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit. — Recalling firm: Ascend Laboratories, LLC — US Nationwide.
- May 10, 2024RECALLRecall (Class II): Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc.,…
CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — US Nationwide.
- May 10, 2024RECALLRecall (Class II): Rizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., U…
CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — US Nationwide.